APA

Neisser-Svae A., Bailey A., Gregori L., Heger A., Jordan S., Behizad M., Reichl H., Römisch J. & Svae T. (20100202). Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. : Vox sanguinis.

Chicago

Neisser-Svae A, Bailey A, Gregori L, Heger A, Jordan S, Behizad M, Reichl H, Römisch J and Svae T-E. 20100202. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. : Vox sanguinis.

Harvard

Neisser-Svae A., Bailey A., Gregori L., Heger A., Jordan S., Behizad M., Reichl H., Römisch J. and Svae T. (20100202). Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. : Vox sanguinis.

MLA

Neisser-Svae A, Bailey A, Gregori L, Heger A, Jordan S, Behizad M, Reichl H, Römisch J and Svae T-E. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. : Vox sanguinis. 20100202.